Literature DB >> 9290505

Two-stage sampling for etiologic studies. Sample size and power.

D Schaubel1, J Hanley, J P Collet, J F Bolvin, C Sharpe, H I Morrison, Y Mao.   

Abstract

Preexisting computerized databases are potentially valuable sources of epidemiologic data. Since such databases are infrequently created specifically for etiologic research, data may be available for the exposure of interest and, through record linkage, for the endpoint of interest, but lacking for potential confounders. Because of the size of these databases, two-stage sampling is an efficient alternative to surveying the entire study population for confounder data. At stage 1, information on exposure and disease status is obtained for the entire study population. Confounder data are collected for probability-selected subsamples at stage 2. Logistic regression is performed on the stage 2 samples, with the parameter estimates and variances appropriately corrected to account for the stage 1 data. In this paper, the authors present methods for determining the required stage 2 sample size in the case of categorical exposure and confounding variables. Sample size tables, power curves, and a computer program have been produced to accommodate a binary exposure and a single binary confounder. With the increasing availability of preexisting yet incomplete databases, the potential for use of two-stage sampling will greatly increase in the future. This investigation provides a basis for estimating the number of participants to sample for the collection of confounder data at the second stage.

Entities:  

Mesh:

Year:  1997        PMID: 9290505     DOI: 10.1093/oxfordjournals.aje.a009298

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  A cautionary note about estimating effects of secondary exposures in cohort studies.

Authors:  K A Ahrens; S R Cole; D Westreich; R W Platt; E F Schisterman
Journal:  Am J Epidemiol       Date:  2015-01-14       Impact factor: 4.897

2.  osDesign: An R Package for the Analysis, Evaluation, and Design of Two-Phase and Case-Control Studies.

Authors:  Sebastien Haneuse; Takumi Saegusa; Thomas Lumley
Journal:  J Stat Softw       Date:  2011-08       Impact factor: 6.440

3.  Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.

Authors:  Lucie Blais; Marie-France Beauchesne; Evelyne Rey; Jean-Luc Malo; Amélie Forget
Journal:  Thorax       Date:  2006-11-22       Impact factor: 9.139

4.  Adaptive sampling in two-phase designs: a biomarker study for progression in arthritis.

Authors:  Michael A McIsaac; Richard J Cook
Journal:  Stat Med       Date:  2015-05-07       Impact factor: 2.373

5.  Infant siblings and the investigation of autism risk factors.

Authors:  Craig J Newschaffer; Lisa A Croen; M Daniele Fallin; Irva Hertz-Picciotto; Danh V Nguyen; Nora L Lee; Carmen A Berry; Homayoon Farzadegan; H Nicole Hess; Rebecca J Landa; Susan E Levy; Maria L Massolo; Stacey C Meyerer; Sandra M Mohammed; McKenzie C Oliver; Sally Ozonoff; Juhi Pandey; Adam Schroeder; Kristine M Shedd-Wise
Journal:  J Neurodev Disord       Date:  2012-04-18       Impact factor: 4.025

6.  Calf-level risk factors for neonatal diarrhea and shedding of Cryptosporidium parvum in Ontario dairy calves.

Authors:  Lise A Trotz-Williams; S Wayne Martin; Kenneth E Leslie; Todd Duffield; Daryl V Nydam; Andrew S Peregrine
Journal:  Prev Vet Med       Date:  2007-06-28       Impact factor: 2.670

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.